Patents by Inventor Yuya Oguro

Yuya Oguro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF
    Publication number: 20110003788
    Abstract: The present invention provides a compound having a superior Smo inhibitory activity and lower toxicity, which is sufficiently satisfactory as a pharmaceutical product. The present invention provides a compound represented by the formula (I) wherein ring A is 5- to 7-membered ring optionally having substituent(s), where substituents are optionally bonded to each other to form a ring; X is O, S or NR1 (R1 is a hydrogen atom or a hydrocarbon group optionally having substituent(s)); R2 is carbamoyl optionally having substituent(s); and R3 is hydroxy optionally having substituent(s), or a salt thereof.
    Type: Application
    Filed: February 25, 2009
    Publication date: January 6, 2011
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Nobuhiro Fujii, Yuya Oguro, Satoshi Sasaki, Shigeru Kondo
  • FUSED HETEROCYCLIC DERIVATIVE AND USE THEREOF
    Publication number: 20090227561
    Abstract: The present invention provides a compound having a superior Smo inhibitory activity and lower toxicity, which is sufficiently satisfactory as a pharmaceutical product. The present invention provides a compound represented by the formula wherein ring A is 5- to 7-membered ring optionally having substituent(s), where substituents are optionally bonded to each other to form a ring; X is O, S or NR1 (R1 is a hydrogen atom or a hydrocarbon group optionally having substituent(s)); R2 is carbamoyl optionally having substituent(s); and R3 is hydroxy optionally having substituent(s), or a salt thereof.
    Type: Application
    Filed: February 25, 2009
    Publication date: September 10, 2009
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Nobuhiro FUJII, Yuya OGURO, Satoshi SASAKI, Shigeru KONDO
  • FUSED HETEROCYCLE DERIVATIVES AND USE THEREOF
    Publication number: 20090163488
    Abstract: A compound represented by the formula (I): wherein Z1, Z2, Z3 and Z4 are the following combination, (Z1,Z2,Z3,Z4)=(CR4,N,CR5,C), (N,N,CR5,C), (N,C,CR5,N), (S,C,CR5,C) or (S,C,N,C); R1 and R2 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R3 is an amino optionally having substituent(s); R4 and R5 are the same or different and each is (1) a hydrogen atom, (2) a halogen atom, (3) a group bonded via a carbon atom, (4) a group bonded via a nitrogen atom, (5) a group bonded via an oxygen atom or (6) a group bonded via a sulfur atom; R3 and R4 optionally form a ring optionally having substituent(s); and a group represented by the formula is a cyclic group optionally having substituent(s), or a salt thereof.
    Type: Application
    Filed: June 4, 2008
    Publication date: June 25, 2009
    Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Yuya OGURO, Shinichi IMAMURA, Douglas R. CARY, Masanori OKANIWA
  • Fused Heterocyclic Derivatives and Use Thereof
    Publication number: 20090137580
    Abstract: The present invention provides a fused heterocyclic derivative showing a potent kinase inhibitory activity and use thereof.
    Type: Application
    Filed: July 5, 2006
    Publication date: May 28, 2009
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Shinichi Imamura, Yuya Oguro